These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3079129)

  • 1. [Doxofylline: pharmacologic profile and a review of clinical studies].
    Grossi E; Biffignandi P; Franzone JS
    Riv Eur Sci Med Farmacol; 1988 Nov; 10(5):415-30. PubMed ID: 3079129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of doxofylline sachets in a pediatric population].
    Bagnato G; Fodale P; Bottari M
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):359-63. PubMed ID: 2701030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitis.
    Bologna E; Laganà A; Terracino D; Bolignari P; Biffignandi P
    J Int Med Res; 1990; 18(4):282-8. PubMed ID: 2227075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.
    Shukla D; Chakraborty S; Singh S; Mishra B
    Expert Opin Pharmacother; 2009 Oct; 10(14):2343-56. PubMed ID: 19678793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of theophylline and doxofylline on airway responsiveness in beagles].
    Sugeta A; Imai T; Idaira K; Horikoshi S; Okamoto M; Adachi M
    Arerugi; 1997 Jan; 46(1):7-15. PubMed ID: 9078607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activities.
    Mikus EG; Kapui Z; Korbonits D; Boér K; Boronkay E; Gyürky J; Révész J; Lacheretz F; Pascal M; Arányi P
    Arzneimittelforschung; 1997 Dec; 47(12):1358-63. PubMed ID: 9450164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxofylline and theophylline are xanthines with partly different mechanisms of action in animals.
    Franzone JS; Cirillo R; Barone D
    Drugs Exp Clin Res; 1988; 14(7):479-89. PubMed ID: 3240706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled clinical study of doxophylline versus aminophylline in the treatment of acute cardiorespiratory insufficiency syndromes].
    Checchini M; Magni M; Scaglione M; Franzini C; Vaccarella A; Omboni E
    Minerva Cardioangiol; 1997 Apr; 45(4):185-90. PubMed ID: 9213834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma.
    Bagnato GF
    Eur Rev Med Pharmacol Sci; 1999; 3(6):255-60. PubMed ID: 11261736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical investigation of a combination preparation of ampicillin, theophylline, papaverine-HCl and guaiacolglyceryl ether. 2. In form of syrup].
    Weuta H
    Arzneimittelforschung; 1974 Dec; 24(12):2044-8. PubMed ID: 4615716
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
    Santra CK
    J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of antitussive agents using 1-p-chlorophenyl-2,3-dimethylamino-butanol-(2).HCl as an example].
    Renovanz HD; Liebrich KG
    Arzneimittelforschung; 1965 Dec; 15(12):1393-411. PubMed ID: 5336456
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitussive therapy in small companion animals.
    Roudebush P
    J Am Vet Med Assoc; 1982 May; 180(9):1105-7. PubMed ID: 7085482
    [No Abstract]   [Full Text] [Related]  

  • 16. Cough: setting the scene.
    Chung KF; Widdicombe JG
    Handb Exp Pharmacol; 2009; (187):1-21. PubMed ID: 18825333
    [No Abstract]   [Full Text] [Related]  

  • 17. Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents.
    Aliprandi P; Castelli C; Bernorio S; Dell'Abate E; Carrara M
    Drugs Exp Clin Res; 2004; 30(4):133-41. PubMed ID: 15553659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the activity and tolerance of hydropropizine, a drug with antitussive activity].
    Boselli G
    Minerva Med; 1972 Jul; 63(51):2782-8. PubMed ID: 4562221
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sputum viscosimetric studies of an antitussive dihydrobenzoxazine derivative].
    Stresemann E; Gürbüz L; Oswald WD
    Arzneimittelforschung; 1974 Dec; 24(12):2053-5. PubMed ID: 4480284
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic and toxicologic studies of m-(1-methyl-3-propyl-3-pyrrolidinyl)phenol (CI-572), an analgetic and antitussive agent.
    Winder CV; Welford M; Wax J; Kaump DH
    J Pharmacol Exp Ther; 1966 Oct; 154(1):161-75. PubMed ID: 4958887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.